One in four advanced lung cancer patients tested for EGFR mutations started on first-line treatment before test results available

Lack of test results may impact treatment effectiveness and survival, survey in Europe, Asia and US reveals.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1JbxQqy